Journal of Clinical Endocrinology & Metabolism, Vol 57, 166-176, Copyright © 1983 by Endocrine Society

ARTICLES

Estrogen receptors in human prostate: evidence for multiple binding sites

P Ekman, ER Barrack, GL Greene, EV Jensen and PC Walsh

The existence of estrogen receptors in the human prostate has long been a controversial issue. This may be explained partly by the apparent heterogeneity of estrogen-binding sites in prostatic tissue. We herein report on multiple binding sites for estrogens in cytosol as well as nuclear preparations of human prostatic tissues. One class of binding sites corresponds to the classical, high affinity estrogen receptor; the Kd for [3H]estradiol binding to the receptor was approximately 0.10 nM and the binding was specific for estrogens. The second class of binding sites appeared to have a Kd for [3H]estradiol in the range of 5- 10 nM. This second, lower affinity class of binding sites markedly influenced studies of the classical receptor even at low ligand concentrations. Saturation analysis should be performed over a wide range of ligand concentrations (0.05-10 nM) to allow separation of the two binding components. Quantitation of estrogen receptor by a single point assay cannot be carried out accurately unless the low affinity binding component can be blocked. Multiple binding sites for estradiol were observed in the cytosol as well as in the nuclear salt extractable and salt-resistant compartments of normal, benign hyperplastic, and cancerous human prostates. Normal peripheral and cancerous prostates contained significantly (P less than 0.01) higher amounts of cytosol estrogen receptor compared to benign hyperplastic tissue.

This article has been cited by other articles:

				O. Imamov, G.-J. Shim, M. Warner, and J.-A. Gustafsson Estrogen Receptor beta in Health and Disease Biol Reprod, November 1, 2005; 73(5): 866 - 871. [Abstract] [Full Text] [PDF]

				T. Tsurusaki, D. Aoki, H. Kanetake, S. Inoue, M. Muramatsu, Y. Hishikawa, and T. Koji Zone-Dependent Expression of Estrogen Receptors {alpha} and {beta} in Human Benign Prostatic Hyperplasia J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1333 - 1340. [Abstract] [Full Text] [PDF]

				G. S. Prins, W. Y. Chang, Y. Wang, and R. B. van Breemen Retinoic Acid Receptors and Retinoids Are Up-Regulated in the Developing and Adult Rat Prostate by Neonatal Estrogen Exposure Endocrinology, September 1, 2002; 143(9): 3628 - 3640. [Abstract] [Full Text] [PDF]

				Y. Zhang, J. Ni, E. M. Messing, E. Chang, C.-R. Yang, and S. Yeh Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells PNAS, May 28, 2002; 99(11): 7408 - 7413. [Abstract] [Full Text] [PDF]

				N. Kuwajerwala, E. Cifuentes, S. Gautam, M. Menon, E. R. Barrack, and G. P. V. Reddy Resveratrol Induces Prostate Cancer Cell Entry into S Phase and Inhibits DNA Synthesis Cancer Res., May 1, 2002; 62(9): 2488 - 2492. [Abstract] [Full Text] [PDF]

				Z. Weihua, S. Makela, L. C. Andersson, S. Salmi, S. Saji, J. I. Webster, E. V. Jensen, S. Nilsson, M. Warner, and J.-A. Gustafsson A role for estrogen receptor beta in the regulation of growth of the ventral prostate PNAS, May 22, 2001; 98(11): 6330 - 6335. [Abstract] [Full Text] [PDF]

				G. B. Tremblay, A. Tremblay, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, F. Labrie, and V. Giguère Cloning, Chromosomal Localization, and Functional Analysis of the Murine Estrogen Receptor {beta} Mol. Endocrinol., March 1, 1997; 11(3): 353 - 365. [Abstract] [Full Text]